Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model
- PMID: 30115913
- PMCID: PMC6095865
- DOI: 10.1038/s41398-018-0216-5
Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model
Abstract
The dopaminergic hypothesis of schizophrenia (SZ) postulates that dopaminergic over activity causes psychosis, a central feature of SZ, based on the observation that blocking dopamine (DA) improves psychotic symptoms. DA is known to have both receptor- and non-receptor-mediated effects, including oxidative mechanisms that lead to apoptosis. The role of DA-mediated oxidative processes in SZ has been little studied. Here, we have used a cell perturbation approach and measured transcriptomic profiles by RNAseq to study the effect of DA exposure on transcription in B-cell transformed lymphoblastoid cell lines (LCLs) from 514 SZ cases and 690 controls. We found that DA had widespread effects on both cell growth and gene expression in LCLs. Overall, 1455 genes showed statistically significant differential DA response in SZ cases and controls. This set of differentially expressed genes is enriched for brain expression and for functions related to immune processes and apoptosis, suggesting that DA may play a role in SZ pathogenesis through modulating those systems. Moreover, we observed a non-significant enrichment of genes near genome-wide significant SZ loci and with genes spanned by SZ-associated copy number variants (CNVs), which suggests convergent pathogenic mechanisms detected by both genetic association and gene expression. The study suggests a novel role of DA in the biological processes of immune and apoptosis that may be relevant to SZ pathogenesis. Furthermore, our results show the utility of pathophysiologically relevant perturbation experiments to investigate the biology of complex mental disorders.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH061675/MH/NIMH NIH HHS/United States
- U01 MH046276/MH/NIMH NIH HHS/United States
- R01 MH067257/MH/NIMH NIH HHS/United States
- U01 MH079470/MH/NIMH NIH HHS/United States
- R01 MH059586/MH/NIMH NIH HHS/United States
- C06 RR020547/RR/NCRR NIH HHS/United States
- R01 MH059566/MH/NIMH NIH HHS/United States
- U01 MH079469/MH/NIMH NIH HHS/United States
- R01 MH094116/MH/NIMH NIH HHS/United States
- R01 MH060870/MH/NIMH NIH HHS/United States
- R01 MH081800/MH/NIMH NIH HHS/United States
- R01 MH059571/MH/NIMH NIH HHS/United States
- R01 MH106575/MH/NIMH NIH HHS/United States
- R01 MH059565/MH/NIMH NIH HHS/United States
- R01 MH059587/MH/NIMH NIH HHS/United States
- R01 MH094091/MH/NIMH NIH HHS/United States
- R21 DA041600/DA/NIDA NIH HHS/United States
- R01 MH059588/MH/NIMH NIH HHS/United States
- RC2 MH090030/MH/NIMH NIH HHS/United States
- R01 MH060879/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
